Introduction: despite the effectiveness of intermittent preventive treatment in pregnancy using sulphadoxine-pyrimethamine (IPTp-SP), the uptake
Introduction
Malaria is a major public health problem with the greatest impact of its burden being in sub-Saharan Africa which accounts for 90% of the global deaths [1] . Most of the burden of disease occurs among populations at highest risk namely; pregnant women and infants [2, 3] . Malaria in pregnancy causes up to 10,000 maternal deaths each year and contributes to high rates of maternal morbidity especially in first-time mothers [4, 5] . Also, 75,000 to 200,000 infant deaths annually are attributable to malaria in pregnancy [3, 6] .
Malaria in pregnancy increases the risk of miscarriage, stillbirth and low birth weight [2, 3] . The World Health Organisation (WHO) and national guideline recommendations on malaria infection during pregnancy include use of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) at each routine antenatal clinic (ANC) visit at least one month apart after the first trimester till delivery [6] . It should be administered under supervision during ANC visits. In Nigeria, ANC clinics are considered an important entry point to target pregnant women for care as 60-70% of women attend ANC clinic at least once during any pregnancy [7, 8] . The 2013 Nigeria Demographic and Health Survey (NDHS) showed that 15% of pregnant women received two doses of SP with at least one dose administered during an ANC visit [9] . The 2015 Malaria Indicator Survey (MIS) however reported an increase from those that received at least one dose (47% of women) and three or more doses (19% of women) [10] . In the south-west zone of Nigeria, there has been an increase of pregnant women that received at least a dose, two or more and three or more doses of IPTp-SP from 23%, 10.5% and 4.3% to 64%, 54% and 20% respectively [9, 10] . In Oyo State, 11% of pregnant women received any SP during an ANC visit while 3% took two or more doses of SP and 1.9% three doses or more of SP [9] .
To address this inadequacy, identification of determinants of IPTp-SP utilisation is critical to the institution of control efforts. We carried out a study to assess factors influencing the utilisation of intermittent preventive treatment in pregnancy in Ogbomoso, Oyo State, Nigeria.
Methods
Study area: Ogbomoso town is situated about 600m above sea level with a mean annual temperature of about 26.2°C. The vegetation is a derived savannah region. Ogbomoso has the tropical wet and dry climate as it falls in the transition zone of guinea-savannah. The region experiences a fairly high uniform temperature, moderate to heavy seasonal rainfall. The relative humidity is within the range 75-95% [11, 12] . Stable malaria transmission occurs in the south-west region with a prevalence of 16.6% [10] . The study sites were Ogbomoso North and South Local Government Areas (LGAs).
Ogbomoso north has an estimated total population of 243,400 persons with women of child bearing age constituting 53,548 [13] .
Ogbomoso south has an estimated total population of 122,863 persons with women of child bearing age constituting 27,029. There are 12 primary health facilities in Ogbomoso North LGA. Ogbomoso Transcripts were then analysed using the thematic approach. KII reports were also analyzed using the thematic approach.
Results
Overall, 400 respondents were included in the analysis. A total number of 430 questionnaires were administered during the study. respondents took the first dose of SP during the second trimester, and 36 took the first dose (11.3%) during the third trimester (Table   3 ). In all, 112 (35.0%) of 320 respondents took their drugs under the direct observation of the health care worker at the health facility (DOT) (Figure 2 ). Regarding what DOT scheme meant, all the six health facility heads said it is Directly Observed Therapy, and it meant the administration of SP to an eligible pregnant woman in the presence of a healthcare worker at the clinic during the antenatal visit. However, the practice of DOT scheme from the FGD report was said not to be adhered to at the health facilities because SP was mostly out of stock in the health facilities ( Table 2 )."The medicines are not usually available at the clinic. The last time I came to clinic I
was not given the medicine that prevents against malaria, it was written out for me to go and buy and then use at home" (PHC OjaIgbo). Also, drug prescriptions given to pregnant women by healthcare workers were purchased from pharmacy stores and used at their homes.
There was an association between IPTp-SP utilization and being employed, having more than two ANC visits, good knowledge on (Table 4) . Also, good knowledge on IPTp-SP was associated with IPTp-SP utilisation (OR= 3.99; 95% CI 2.31 -6.88). FGD report respondents' good knowledge on IPTp-SP as "A form of treatment given to pregnant women to prevent the occurrence of malaria fever" (PHC Kajola). Also "Fansidar, as we were being told during our clinic visit is the recommended medicine for the prevention of malaria during pregnancy" (PHC Katangua). KII report showed that the facility heads were knowledgeable about IPTp-SP.
All the six health facility heads interviewed knew IPTp using SP as a chemoprophylaxis given to pregnant women after 13 weeks of gestation until the time of delivery at a monthly interval for the prevention of malaria. Concerning the national policy on IPTp, two out of six facility heads gave an update on the policy. One (from PHC Idi-Oro) said the practice of directly observed therapy of IPTp in which a pregnant woman takes the SP in the presence of the healthcare worker at the clinic should be observed. The second facility head (PHC Ahoyaya) said at least two doses of SP was used before;
presently SP is given after 13 weeks of gestation till delivery. 
Discussion
We found that early booking for ANC, more than two visits to ANC, 
Conclusion
The findings of this study show that more than two visits to ANC, 
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